Hyperliquid’s $9 billion in volume and profitable mechanisms will make vampire attacks on the network’s liquidity a challenge.
You might also be interested in reading Regeneron Pharmaceuticals declares its first-ever dividend of $0.88, announces $3.0B buyback.